Resnick Joshua 4
4 · Vor Biopharma Inc. · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Resnick Joshua
Director
Transactions
- Award
Stock Option (right to buy)
2021-02-05+16,900→ 16,900 totalExercise: $18.00Exp: 2031-02-04→ Common Stock (16,900 underlying)
Footnotes (2)
- [F1]1/36th of the shares underlying the option vest in equal monthly installments commencing on March 5, 2021, provided that the Reporting Person remains continuously engaged by the Issuer on each such vesting date.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"), RA Capital Nexus Fund, L.P. (the "Nexus Fund") and a separately managed account (the "Account"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund, the Nexus Fund and the Account to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.